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Crystal Structure of the Hemochromatosis Protein
HFE and Characterization of Its Interaction
with Transferrin Receptor
His-41 to aspartate increases the relative risk of devel-
oping hemochromatosis in individuals who areheterozy-
gous for the Cys260Tyr mutation (Feder et al., 1996;
Beutler, 1997). Unlike the Cys260Tyr substitution, the
His41Asp substitution does not prevent b2m association
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The homology between HFE and MHC molecules
does not suggest an obvious role for HFE in iron homeo-
Summary stasis, since class I MHC molecules function in peptide
presentation to T cells. A connection between HFE and
HFE is an MHC-related protein that is mutated in the iron absorption was recently made with the demonstra-
iron-overload disease hereditary hemochromatosis. tion that HFE associates with transferrin receptor (TfR)
HFE binds to transferrin receptor (TfR) and reduces (Parkkila et al., 1997; Feder et al., 1998) and decreases
its affinity for iron-loaded transferrin, implicating HFE its affinity for iron-bound transferrin (diferric Tf [Fe-Tf])
in iron metabolism. The 2.6 AÊ crystal structure of HFE by 5- to 10-fold (Feder et al., 1998). The Tf/TfR system
reveals the locations of hemochromatosis mutations is a well-established pathway by which cells absorb
and a patch of histidines that could be involved in iron. Fe-Tf in the blood binds to cell-surface TfR and
pH-dependent interactions. We also demonstrate that triggers endocytosis of the Tf/TfR complex (reviewed in
soluble TfR and HFE bind tightly at the basic pH of the Richardson and Ponka, 1997). Upon exposure to the
cell surface, but not at the acidic pH of intracellular acidic pH of the endosome, iron is released from Tf and
vesicles. TfR:HFE stoichiometry (2:1) differs from TfR: enters a chelatable intracellular pool from which it is
transferrin stoichiometry (2:2), implying a different utilized for the metabolic needs of the cell or incorpo-
mode of binding for HFE and transferrin to TfR, consis- rated into the storage protein ferritin. Apo-Tf remains
tent with our demonstration that HFE, transferrin, and bound to TfR at the low pH of the acidic vesicle (#pH
TfR form a ternary complex. 6.0) and the apo-Tf/TfR complex is then recycled to the
cell surface where apo-Tf dissociates at the pH of blood
(zpH 7.4). The role of TfR in iron uptake has been wellIntroduction
characterized but the association with HFE was pre-
viously unnoticed, perhaps because HFE is not ex-Hereditary hemochromatosis (HH) is a disease charac-
pressed in commonly used cultured cell systems (e.g.,terized by the excessive deposition of iron in different
HeLa cells, 293 cells; J. N. F, unpublished data), possiblyorgans of the body leading to multiorgan dysfunction.
an adaptive response to allow increased iron uptake.HH is the most common autosomal recessive disorder
The functional consequences of the primary mutationaffecting individuals of Northern European descent. Ap-
in HFE, Cys260Tyr, were addressed by the demonstra-proximately 1 in 200 to 1 in 400 Caucasian individuals
tion that, unlike wild-type HFE, the Cys260Tyr mutanthave HH, leading to an estimated carrier frequency of
does not interact with TfR and therefore does not de-between 1 in 8 and 1 in 10 (Merryweather-Clarke et al.,
crease TfR's affinity for Fe-Tf (Feder et al., 1998). In1997, and references therein). A candidate gene for HH
contrast, the His41Asp mutant form of HFE still interactswas identified near, but not in, the majorhistocompatibil-
with TfR but does not decrease the affinity for Fe-Tf toity complex (MHC) (Feder et al., 1996). The gene product
the same extent as wild-type HFE. The results describedHFE is a 343 residue type I transmembrane glycoprotein
above suggest that when HFE is expressed in the samethat is homologous to class I MHC proteins and associ-
cell as TfR, less Tf-associated iron will be taken into theates with the class I light chain b2-microglobulin (b2m)
cell. In the absence of HFE, as in the hemochromatotic(Feder et al., 1996). Between 69% and 100% of HH
individual carrying the Cys260Tyr mutation, more ironpatients are homozygous for a mutation (845G→A) that
would be brought into cells, ultimately resulting in in-converts Cys-260 to a tyrosine (reviewed in Cuthbert,
creased iron deposition in cells that normally use HFE1997), preventing formation of a disulfide bond in the
for modulation of iron intake.a3 domain and abrogating b2m association as well as
In this study, we have determined the X-ray crystalcell-surface expression of the protein (Feder et al., 1997;
structure of a soluble form of human HFE and character-Waheed et al., 1997). A second mutation that converts
ized the interactions between HFE, Tf, and TfR. Com-
bined with the observation that HFE reduces the affinity
of TfR for Fe-Tf (Feder et al., 1998), our results support‖ These authors contributed equally to this work.
a model in which HFE is involved in the canonical iron# Present address: Cold Spring Harbor Laboratory, 1 Bungtown
Road, Cold Spring Harbor, NY 11724. absorption pathway and regulates iron intake by a
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a symmetry that deviates from the pseudo-dyad symme-Table 1. Data Collection and Refinement Statistics for HFE
try relating antibody constant domains. Specifically, the
Unit cell dimensions HFE domains are related by a 1618 rotation and a 13 AÊ
a, b, c (AÊ ) 68.8, 100.1, 147.6
translation. This relative orientation is in the range seenSpace group P212121
for the a3-b2m relationship in class I molecules (1468-Temperature (8C) 2150
1608 rotation, 13±14 AÊ translation), CD1 (1708 rotation,
Data Processing 12 AÊ translation) (reviewed in Zeng et al., 1997), and
Resolution (AÊ ) 15.0±2.6 (2.7±2.6) FcRn (1578 rotation, 13 AÊ translation) (Burmeister et al.,
Observations 187,780 1994a).
Unique reflections 32,145 (3,435) The HFE residue involved in the Cys260Tyr mutation
Completeness (%) 98.1 (96.7) is in the a3 domain, where it disulfide bonds with Cys-
I/s 23.7 (3.2)
203 (Figures 1A and 1C). His-41, the residue substitutedRmergea (%) 5.9 (42.1)
in the His41Asp mutation, is in a loop in the a1 domain,
Refinement where it forms a salt bridge with Asp-73 (Figure 1B).
Substitution of an aspartate at position 41 would beResolution 15.0±2.6
Reflections in working set 30,215 unlikely to affect the overall protein fold but would dis-
Reflections in test set 1,555 rupt the salt bridge with Asp-73, perhaps leading to a
Rfreeb (%) 27.7 local rearrangement of the loop to avoid juxtaposition
Rcrystb (%) 23.3 of two negative charges.
Rms deviations from ideality The surface of HFE includes a cluster of four histidine
Bond lengths (AÊ ) 0.009 residues accounting for one-third of the total histidines
Bond angles (deg) 1.4
in the human HFE heavy chain (Feder et al., 1996) (Figure
Number of nonhydrogen atoms 1D). The clustering of these histidines with a nearby
Protein 6068 tyrosine (HFE Tyr-118) bears some resemblance to the
Water 25 composition of mononuclear iron±binding sites in sev-
a Rmerge (I) 5 (S|(I(i) 2 ,I(h).|)/SI(i), summed over all reflections and eral proteins (Howard and Rees, 1991). Thus far, analy-
all observations, where I(i) is the ith observation of the intensity ses of crystals soaked at near-neutral or basic pH in
of the hkl reflection and ,I(h). is the mean intensity of the hkl iron (10 mM Fe(III)-NTA or 10 mM Fe(II)(NH4)2SO4) orreflection.
chemically similar metals (10 mM NiCl2 or 10 mM MnCl2)
b Rcryst (F) 5
Sh
|| Fobs(h)|2|Fc(h)||
Sh
| Fobs (h)| , where Fobs and Fc are the observed and have not yielded evidence of metal binding in this region
(M. J. B., J. A. L., and P.J.B., unpublished data). How-calculated structure factor amplitudes for the hkl reflection. Rfree is
ever, the conditions under which the crystals werecalculated for a set of reflections that were not included in atomic
refinement (BruÈnger, 1992b). soaked may not have been optimal for metal binding.
Groove Narrowing in HFE Prevents Peptide Binding
Although the overall structure of HFE resembles class Imechanism that involves binding to TfR in a pH-depen-
MHC molecules, HFE lacks a functional peptide-binding
dent manner.
groove. Whereas class I molecules bind short (8±10 resi-
dues) peptides (Rammensee et al., 1993), peptides are
Results
not associated with HFE (Table 2). The crystal structure
reveals the reason for HFE's lack of peptide binding:
Structure of HFE its counterpart of the MHC peptide-binding groove is
Soluble HFE/b2m heterodimers were expressed in Chi- narrowed by a translation of the a1 helix bringing it z4
nese hamster ovary (CHO) cells. The crystal structure AÊ closer to the a2 helix (Figure 2A). A striking feature of
was determinedto 2.6 AÊ by molecular replacement using the HFE groove is that the entire a2 helix is almost
a 2.0 AÊ structure of the human class I MHC molecule identically positioned to the a2 helix in class Imolecules,
HLA-A2 (Collins et al., 1994). The refined structure has whereas in the MHC-related molecules FcRn and CD1
good stereochemistry (Table 1) and 94% of the residues both helices are repositioned.
within allowed regions of the Ramachandran plot as The narrower groove in HFE results in burial of resi-
defined by Kleywegt and Jones (1996). dues analogous to those forming pockets that interact
The overall structure of HFE resembles MHC class I with peptides in class I binding clefts. Class I pockets
molecules (such as HLA-A2, with which it shares 37% A and F accommodate the N and C termini of bound
sequence identity). In both, the a1 and a2 domains form peptides and are lined with mostly conserved residues,
a platform composed of eight antiparallel b strands while the intermediate pockets (B to E) interact with
topped by two antiparallel a helices (Figure 1B) posi- peptide side chains and contain residues that vary (Fig-
tioned on top of two immunoglobulin constant-like do- ure 2B; Saper et al., 1991; Matsumura et al., 1992). Over-
mains: a3 and the light chain b2m (Figure 1A). The indi- all, about half of the HFE residues located in positions
vidual domains in HFE can be superimposed upon the analogous to class I pockets A through F are buried,
corresponding domains in HLA-A2 with rms deviations preventing them from an interaction with peptide (Table
of less than 1.5 AÊ for most Ca atoms, comparable to 3). In class I pocket A, tyrosines 7, 59, 159, and 171
superpositions of two other class I MHC-related pro- interact with the peptide N terminus, and Trp-167 is at
teins: the neonatal Fc receptor (FcRn) (Burmeister et al., the groove rim in many class I alleles (Figure 2B). In
1994a) and CD1, a class Ib MHC protein (Zeng et al., HFE, only two of the tyrosines are conserved (HFE Tyr-
1997) (see Experimental Procedures). In HFE, as in class 10 and Tyr-160) and Tyr-10 is buried (Table 3). In addi-
tion, the side chain of HFE Gln-168 (class I residue 167)I and class I-related proteins, a3 and b2m interact with
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Figure 1. Crystal Structure of HFE and Comparison to a Class I MHC Molecule
(A) Ribbon diagram shows that HFE resembles class I molecules in the fold of the heavy chain (blue) and in its association with the b2m light
chain (green). Cys-260, the residue substituted in the Cys260Tyr mutation, disulfide bonds with Cys-203.
(B) Ribbon drawing of a top view of the HFE a1-a2 platform. His-41 (red), the site of the His41Asp mutation, interacts with Asp-73 (green).
(C) The HFE model in the region of the Cys-260ÐCys-203 disulfide bond is shown superimposed on a 2Fo2Fc annealed omit electron density
map (Hodel et al., 1992) contoured at 1s. The average B factor for the residues shown is 48 AÊ 2.
(D) Close-up of a histidine cluster and nearby tyrosine located underneath the right-hand side of the platform. His-94 is found in class I MHC
molecules (class I His-93); His-89 and His-123 are present only in human (Feder et al., 1996), rat (EMBL accession number AJ001517), and
mouse (Hashimoto et al., 1997) HFE. His-87 is present in human, but not mouse or rat, HFE.
(A), (B), and (D) were made with Molscript (Kraulis, 1991) and rendered with Raster3D (Merritt and Murphy, 1994). (C) was prepared with O
(Jones and Kjeldgaard, 1997).
points into the groove to occlude pocket A (Figure 2C) bind peptides with side chains larger than alanine; e.g.,
Trp-114 on the HFE groove floor (Figure 2C).in a manner reminiscent of Arg-164 in FcRn (Burmeister
et al., 1994a). The HFE counterpart of the peptide-binding groove
is distinct from the grooves in two other MHC classIn addition to resulting in burial of pocket residues,
the groove narrowing causes several residues in HFE I±related proteins of known structure (Figure 2A): FcRn,
which has an almost completely closed groove (Bur-to occupy positions that would clash with a bound pep-
tide. To identify only those HFE residues that would meister et al., 1994a), and CD1 (Zeng et al., 1997), which
contains a deep hydrophobic groove that binds lipidsclash with all bound peptides regardless of sequence,
the side chains in four defined nonameric peptides (Beckman et al., 1994) and long (12±22 residues) hy-
drophobic peptides (CastanÄ o et al., 1995). The total sur-bound to HLA-A2 (Madden et al., 1993) were truncated
to alanines and superimposed upon HFE. In total, eight face area of the groove in HFE (z415 AÊ 2) is intermediate
between that in FcRn (z235 AÊ 2) and class I moleculesside chains from the HFE a1 helix and two side chains
from the a2 helix are incompatible with peptide binding (z760 AÊ 2). CD1 has a narrower but deeper groove than
class I grooves, with the most extensive surface area(Figure 2C). The clashes are caused both by the transla-
tion of the a1 helix toward the a2 helix and by the pres- of all (z1440 AÊ 2) (see Experimental Procedures).
The structural rearrangements resulting in grooves ofence of larger side chains in HFE as compared to class
I (HFE Leu-69 versus class I Val-67, HFE Trp-72 versus various sizes and shapes differ in HFE, FcRn, and CD1.
In contrast to HFE, in which the a2 helix is positionedclass I His-70, HFE Met-75 versus class I Thr-73, and
HFE Arg-153 versus class I Val-152). Additional HFE similarly to its counterpart in class I molecules, the a2
helix of FcRn or CD1 is kinked about a hinge point nearresidues probably also contribute to HFE's inability to
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that the HFE-TfR interaction does not require the trans-Table 2. Amino Acids Recovered from Acid Elutionsa
membrane domain of either protein (Feder et al., 1998),
Cycle Number HFE FcRn UL18 soluble TfR is an appropriate reagent for analyses of
1 2.1 5.9 86.0 HFE-TfR binding.
2 0.5 4.7 75.1 In order to measure the affinity between HFE and TfR,
3 0.4 0.7 36.9 HFE was covalently immobilized to a biosensor chip
4 0.8 7.6 19.8 using primary amine chemistry (see Experimental Proce-
5 0.0 0.0 11.3
dures). At pH 7.5, TfR binds immobilized HFE with high6 3.5 0.0 4.0
affinity (KD z0.6 nM). The interaction was not affected7 1.0 0.2 3.7
8 0.0 0.6 6.5 by the addition of the iron chelator pyrophosphate (PPi)
9 1.9 9.5 4.3 during the assay (data not shown), demonstrating that
10 0.0 0.3 1.3 HFE binding to TfR does not require iron. In contrast to
the high affinity binding between TfR and HFE, Tf doesa Total yield (pmols) of amino acids from each N-terminalsequencing
cycle for acid eluates derived from equivalent amounts of HFE, not bind HFE (Table 4). Thus, the HFE-mediated de-
FcRn, and UL18. Previous studies established that UL18 and classi- crease in the affinity of TfR for Fe-Tf (Feder et al.,
cal class I molecules, but not FcRn, associate with endogenous 1998) does not involve a direct interaction between
peptides when expressed as soluble proteins in CHO cells (Chap-
HFE and Tf.man and Bjorkman, 1998, and references therein). Only those amino
When the HFE-TfR interaction was monitored at pHacid residues that showed an increase in the absolute amount recov-
7.5 in the reverse orientation by injecting HFE over pri-ered compared to the previous cycle were considered significant.
Analysis of the HFE and FcRn eluates by matrix-assisted, laser mary amine±coupled TfR, the affinity is significantly
desorption, time-of-flight mass spectrometry using a PerSeptive lower (KD z240 nM) (Table 4). In order to investigate
Biosystems ELITE mass spectrometer did not reveal the presence whether this decreased affinity was a result of the
of N-terminally blocked peptides (data not shown).
method of TfR immobilization (see Experimental Proce-
dures), we injected HFE over TfR that was noncovalently
coupled via its 6xHis-tag to a biosensor chip derivatized
a proline. HFE is the only class I homolog that has a with nickel nitrilotriacetic acid (Ni-NTA). However, since
proline at this position (HFE Pro-166, FcRn Pro-162, and HFE interacts directly with the Ni-NTA chip at high HFE
CD1 Pro-169) in which a kink is not seen. Instead, HFE concentrations (.50 nM; Figure 3C) (perhaps due to
Pro-166 is accommodated without significant structural nickel binding to the His cluster on HFE; Figure 1D),
rearrangements relative to class I molecules (Figure 2A), we could not obtain a precise value for the KD of this
which contain a valine at this position (Val-165). The interaction. Nonetheless, the approximate affinity and
reason appears to be that a local distortion, perhaps dissociation rate derived from the interaction of HFE
related to a neighboring disulfide bridge involving class with His-tagged TfR captured on the Ni-NTA chip are
I Cys-164, occurs at this point in class I molecules, and consistent with those derived using covalently immobi-
the -NH group of the subsequent class I residue (Val- lized TfR and not with those derived using soluble TfR
165) is not hydrogen bonded in the helix. Thus, this and immobilized HFE (Figure 3; Table 4). Thus, TfR binds
position in the a2 helix can accommodate a proline as to immobilized HFE more tightly than HFE binds to im-
occurs in HFE without altering the structure. mobilized TfR.
The biosensor studies demonstrate that TfR and HFE
HFE Binds Tightly to TfR at pH 7.5 interact strongly with an affinity either comparable to
but Not at pH 6 the affinity of TfR for its Tf ligand or no more than 100-
In order to further characterize the interaction of HFE fold weaker (Figure 3; Table 4). We cannot ascertain the
with TfR, we expressed a soluble form of TfR (residues reason for the coupling-dependent affinity difference of
121±760) corresponding to a previously characterized the HFE-TfR interaction, but note that coupling-depen-
proteolytic fragment purified from human placenta (Tur- dent differences have been observed in other biosensor
kewitz et al., 1988a). Since TfR is normally a disulfide- assays (Kuziemko et al., 1996; Vaughn and Bjorkman,
linked homodimeric type II membrane glycoprotein 1997). In those cases, the higher affinity values corre-
(Schneider et al., 1984), we first verified that the proper- sponded more closely to values derived from cell bind-
ties of soluble recombinant TfR are similar to those of ing assays. By analogy, we expect the higher affinity (KD
its membrane-bound counterpart. Analytical ultracen- z0.6 nM; Table 4) to be more relevant for the physiologi-
trifugation demonstrated that soluble TfR is dimeric cal interaction of TfR and HFE so that TfR binds HFE at
(data not shown). In a surface plasmon resonance (SPR) least as tightly as it binds its Tf ligand. In vivo, complex
based assay, soluble TfR binds Fe-Tf with a KD z3 nM formation between TfR and HFE is likely to be even more
at pH 7.5 (Figure 3; Table 4; KD's cited in the text are favored than predicted from the affinities determined
the median of the range of values derived under different in these biosensor studies due to tethering of the two
experimental conditions), consistent with the affinity of proteins on the same membrane.
Fe-Tf for membrane-bound TfR (5 nM; Richardson and At pH 6.0, HFE shows either only very weak binding
Ponka, 1997, and references therein). Soluble TfR also (KD . 10 mM) or no detectable binding to TfR (Table 4;
retains membrane-bound TfR's pH-dependent affinity Figures 3A and 3B). Thus, the TfR-HFE binding affinity
for apo-Tf, binding at pH 6.0 (KD z8 nM) but not at pH drops from nanomolar to essentially undetectable over
7.5 (Figure 3; Table 4). Since soluble TfR retains the a change in pH of less than two units (Table 4). Histidine
binding properties and physical characteristics of mem- residues, with their near-neutral pKa's, are likely candi-
dates to mediate pH-dependent binding over this pHbrane-bound TfR and because previous studies implied
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range (Fersht, 1985). Specifically, neutral histidines Insight into the molecular mechanism of HFE in iron
uptake regulation is provided by the recent discoverycould be involved in binding of TfR and HFE at the
pH of the cell surface (zpH 7.4) with protonation of that HFE binds to TfR (Parkkila et al., 1997; Feder et al.,
1998) and thereby reduces its affinity for Fe-Tf (Federhistidines in acidic vesicles (zpH 6.0) then mediating
the dissociation of TfR and HFE. The prominent patch et al., 1998). The HH mutations either eliminate the bind-
ing of HFE to TfR (Cys260Tyr) or alter HFE's ability toof histidines in HFE (Figure 1D) and/or His-41, the site
of one of the HH mutations, could be involved in these reduce the affinity between TfR and Fe-Tf (His41Asp)
(Feder et al., 1998). How perturbation of the HFE-TfRsorts of pH-dependent interactions (see Discussion).
association might result in increased iron absorption in
the small intestine, as seen in patients with HH (McLarenHFE and Tf Bind to TfR with Different
et al., 1991), will require additional studies (for furtherStoichiometries and Can Bind Simultaneously
discussion see Feder et al., 1998). However, a higherto Form a Ternary Complex
affinity between TfR and Fe-Tf due to the absence ofWe used a gel filtration assay to determine the stoichi-
fully functional HFE could lead to increased iron uptakeometry of the interaction of TfR with Tf and with HFE.
by cells in some tissues, ultimately causing excess ironAt pH 7.5, TfR and Fe-Tf form a complex with 2:2 stoichi-
deposition in the major organs, a primary defect in HHometry (Figure 4), consistent with earlier results (Enns
(Bacon and Tavill, 1996).and Sussman, 1981) and with the hypothesis that each
To further define the HFE-TfR association, we havepolypeptide chain in the TfR homodimer binds to one
begun to characterize the interaction between solubleTf molecule. At the same pH, TfR complexes with HFE
forms of HFE and TfR. Considering that HFE was onlywith 2:1 stoichiometry (Figure 4), corresponding to one
recently identified as a component in the TfR pathway,TfR homodimer binding only one HFE. At pH 6.0, HFE
HFE and TfR form a surprisingly high affinity complexand TfR do not form a complex that is observed on the
at the slightly basic pH found at the cell surface (KD z0.6sizing column (data not shown), as expected from the
nM), while at the acidic pH corresponding to intracellularbiosensor studies (Table 4).
vesicles there is little or no binding of HFE to TfR. TheThe observation that HFE and Tf bind to TfR with
pH-dependent affinity of the HFE-TfR interaction is remi-different stoichiometries implies that TfR usesa different
niscent of the interaction between TfR and apo-Tf andmode of binding to interact with each protein, which in
of the interaction between FcRn and its immunoglobulinturn suggested that a ternary complex of TfR, Tf, and
G (IgG) ligand, interactions that each show a sharp pHHFE could form. We used an anti-HFE monoclonal anti-
dependence in the range between pH 6 and pH 7.5body (1C3) that does not interfere with HFE binding
(reviewed in Richardson and Ponka, 1997; Junghans,to TfR to investigate whether Tf coimmunoprecipitates
1997). In the TfR-apo-Tf and FcRn-IgG systems, thealong with HFE and TfR. HFE, TfR, and Fe-Tf were incu-
receptors' functions involve trafficking through acidicbated at a 1:2:2 molar ratio (corresponding to one HFE,
compartments as a complex with ligand and release ofone TfR homodimer, and two molecules of Fe-Tf), fol-
ligand at the slightly basic pH of blood. The sharp pHlowed by immunoprecipitation. SDS-PAGE analysis
dependence of the HFE-TfR interaction, an unusual fea-demonstrates that bands corresponding to HFE, TfR,
ture of a protein±protein interaction unless it is requiredand Fe-Tf are present regardless of the order of addition
for pH-regulated binding during trafficking, implies thatof the proteins (Figure 5).
HFE enters the cell along with TfR-Tf complexes, then
dissociates from TfR in acidic vesicles. Thus, studies of
Discussion HFE trafficking and/or recycling might be pertinent to
HFE's role in the regulation of iron homeostasis.
HFE was initially implicated in iron metabolism by the Histidine residues are likely candidates for mediating
discovery that it is mutated in patients afflicted with pH-dependent protein interactions at pH values near
HH, an iron-overload disorder (Feder et al., 1996). The neutral. Histidines have a pKa of 6.6 in model compounds
majority of HH patients are homozygous for a single site (Fersht, 1985) and are therefore likely to be neutral at
mutation leading to the Cys260Tyr substitution (re- the basic pH of blood and to carry a positive charge at
viewed in Cuthbert, 1997) that disrupts the interaction the pH of acidic intracellular vesicles. The FcRn-IgG
between HFE and its b2m light chain and prevents cell- system is a well-characterized example of a pH-depen-
surface expression (Feder et al., 1997; Waheed et al., dent affinity difference mediated through titration of his-
1997). The 2.6 AÊ crystal structure of HFE confirms that, tidines (Vaughn and Bjorkman, 1998). By analogy, the
as predicted from its sequence (Feder et al., 1996), pH dependence of the HFE-TfR interaction could be due
HFE closely resembles class I MHC molecules and that to a favorable interaction at neutral or slightly basic pH
Cys-260 is involved in a disulfide bridge analogous to involving uncharged histidines on one or both proteins,
those found in class I MHC a3 domains. The residue which becomes unfavorable upon acquiring positive
involved in a secondmutation found in someHH patients charge(s) by protonation at acidic pH. The distribution
(His41Asp) is located in a loop within the a1 domain. This of histidines in TfR is unknown, but the HFE structure
mutation may alter the structure of the protein locally includes an intriguing patch of histidines (Figure 1D) that
by a loop rearrangement to avoid juxtaposition of the could act as a pH-dependent switch to modulate the
substituted aspartate with Asp-73, a residue with which interaction. In addition to the potential involvement of
His-41 normally interacts. The existence of these muta- the clustered histidines in intermolecular pH-dependent
tions in HH patients implies that properly folded HFE is interactions, HFE His-41 is involved in an intramolecular
pH-dependent interaction in that it forms a salt bridgerequired for prevention of iron overload.
Cell
116
Figure 2. The Counterpart of the Class I Peptide-Binding Groove is Narrowed in HFE by Translation of the a1 Helix
(A) Ca stereo superpositions based on Ca atoms in the platform b strands of HFE with class I and class I±related proteins. Top, HLA-A2
(green, including a ball-and-stick representation of bound peptide; PDB code 2CLR) and HFE (magenta). Heavy chains share 37% amino acid
sequence identity. Middle, Rat FcRn (green; PDB code 1FRU) and HFE (magenta). Heavy chains share 28% sequence identity. HFE Pro-166
(labeled) is analogous to FcRn Pro-162, located at a kink in the FcRn a2 helix. Bottom, Mouse CD1 (green) (Zeng et al., 1997) and HFE
Structure and Function of HFE
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Table 3. Comparison of Residues in Peptide-Binding Grooves of HLA-A2 and HFE
HLA-A2 Pocketa HFE Pocketa Clash with Peptide?b
Met-5 A Leu-8 Buried No
Tyr-7 A, B Tyr-10 Buried No
Phe-9 B, C Phe-12 Buried No
Met-45 B Val-46 B No
Tyr-59 A Met-61 A No
Glu-63 A, B Leu-65 A, B No
Lys-66c A Ser-68 A Yes
Val-67 B Leu-69 B Yes
His-70 B, C Trp-72 B, C Yes
Thr-73c C Met-75 C Yes
Val-76 Not in a pocket Val-78 Not in a pocket Yes
Asp-77c F Asp-79 Buried Yes
Thr-80c F Thr-82 F Yes
Leu-81 F Ile-83 Buried Yes
Arg-97 C, E Val-98 Buried No
Tyr-99 A, B, C, D Leu-100 Buried No
His-114 C, D, E Trp-114 C, D, E No
Tyr-116 C, F Tyr-116 Buried No
Tyr-118 F Tyr-118 F No
Tyr-123 F His-123 Buried No
Ile-124 F Leu-124 Buried No
Thr-143 F Thr-143 Buried No
Trp-147 E, F Trp-147 E, F No
Val-152 E Arg-153 E Yes
Leu-156 D, E Asn-157 D, E No
Tyr-159 A, D Tyr-160 A, D No
Trp-167 A Gln-168 A Yes
Tyr-171 A Leu-172 A No
a Pocket residues in the peptide binding groove of HLA-A2 are defined as having $5.0 AÊ 2 of solvent accessible surface area with a 1.4 AÊ
probe radius but ,5.0 AÊ 2 with a 5.0 AÊ probe radius. Analogous residues in HFE are listed for comparison. ªBuriedº indicates an HFE residue
that is inaccessible to a 1.4 AÊ probe. Surface areas were calculated excluding water molecules and bound peptide using the coordinates of
HLA-A2 (PDB code 2CLR) and HFE.
b Steric clashes with polyalanine peptides defined as described (Figure 2C).
c Residues that have accessible surface in the binding cleft of HLA-A2 and hence constitute pockets (Saper et al., 1991), but are accessible
to a 5.0 AÊ probe and do not meet the criterion for pocket residues described above.a
with Asp-73 (Figure 1B) that would be more stable at groove is not large enough to accept a loop from TfR
in the position where a peptide would bind to a class Iacidic compared to basic pH. Interestingly, this residue
is mutated to aspartate in some HH patients (Feder et molecule. Alternatively, HFE may use an entirely differ-
ent surface for binding ligands. A precedent for an MHC-al., 1996; Beutler, 1997), destroying its potential to form
a pH-dependent salt bridge. related molecule that binds ligands using a molecular
surface other than the groove is found in the exampleBecause HFE is structurally similar to MHC molecules,
another candidate for its ligand recognition site is the of FcRn. Like HFE, FcRn functions in a recognition event
(binding and transporting IgG) that bears no resem-HFE counterpart of the MHC peptide-binding groove, a
characteristic feature of classical class I molecules and blance to the antigen presentation functions of classical
class I MHC molecules and CD1, and its counterpart ofCD1. Biochemical and structural analyses demonstrate
that HFE does not bind peptides or other small mole- the MHC peptide-binding groove is closed and is not
the binding site for IgG (Burmeister et al., 1994b).cules in this region. Although the region of HFE involved
in ligand binding remains to be established, the nar- The interaction between HFE and TfR will ultimately
require a detailed characterization of both proteins,rowing of the HFE groove compared to class I molecules
suggests that HFE does not use what remains of its which we have initiated by an analysis of their complex.
Our observation that the stoichiometry of TfR's interac-groove for ligand recognition in a manner analogous to
peptide binding in MHC molecules. That is, although tion with Fe-Tf (2:2) differs from the stoichiometry of its
interaction with HFE (2:1) implies that HFE and Tf bindTfR could bind to this general area on HFE, the HFE
(magenta). Heavy chains share 22% sequence identity. HFE Pro-166 (labeled) is analogous to CD1 Pro-162, located at a kink in the CD1 a2
helix.
(B) Peptide-binding groove of HLA-A2 with labeled binding pockets.
(C) HFE counterpart of the class I binding groove showing residues that would clash with a bound peptide. HFE side chains shown in white
(same in HFE and HLA-A2) and green (different in HFE and HLA-A2) have at least two steric clashes with polyalanine versions of four different
nonameric peptides (from HLA-A2 structures, PDB codes 1HHG, 1HHI, 1HHJ, and 1HHK; Madden et al., 1993) that were superimposed upon
HFE after alignment of HLA-A2 and HFE. Steric clashes are defined as occurring when atoms are closer than the sum of their van der Waals
radii minus 0.4 AÊ . The blue side chain would clash with peptides containing side chains larger than alanine.
All panels were made with Molscript (Kraulis, 1991) and rendered with Raster3D (Merritt and Murphy, 1994).
Cell
118
Figure 3. Biosensor Assays of TfR-Tf and TfR-HFE Binding
In each panel, the injected protein is indicated in front of an arrow pointing to the immobilized protein (coupled covalently via primary amines
[A and B] or coupled noncovalently via a 6xHis-tag to a Ni-NTA chip [C]). The model used to fit the data is listed along with a derived affinity
constant(s). ªHeterogeneousº refers to two classes of noninteracting binding sites on the coupled protein with different KD's (KD,1 and KD,2),
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of the processed HFE chain as identified by N-terminal sequencingdifferently to TfR, most likely to distinct regions of the
is residue 1; previous numbering systems starting at the initial methi-receptor (Figure 4). Regardless of where these proteins
onine of the signal peptide refer to it as 23 (Cuthbert, 1997, andbind to TfR, the finding that HFE and Fe-Tf can bind
references therein).
simultaneously to TfR to form a ternary complex demon- Purified HFE or the control proteins FcRn and UL18 (0.25 mg of
strates that HFE does not occlude both Tf-binding sites each) were treated with acetic acid and analyzed for the presence
of bound peptides using established methods (RoÈtzschke et al.,on TfR. Since TfR is homodimeric (Schneideret al., 1984;
1990) as previously described for UL18 and FcRn (Chapman andTurkewitz et al., 1988a), it seems reasonable to postulate
Bjorkman, 1998). Low±molecular weight filtrates of the acid eluatesa 2-fold symmetric structure for a Tf-TfR complex in
were lyophilized, and half of each eluate was analyzed by automatedwhich each polypeptide chain binds toone Tf to produce
Edman degradation using an Applied Biosystems model 477A pro-
2:2 stoichiometry (Enns and Sussman,1981). The finding tein sequencer for pool sequencing (Table 2).
that only one HFE binds to a TfR homodimer raises the
possibility that HFE binding induces asymmetry in the Crystallization and Data Collection
TfR homodimer, resulting in only a single optimal HFE- Crystals (space group P212121; a 5 68.8 AÊ , b 5 100.1 AÊ , c 5 147.6
binding site. The resulting asymmetric receptor might AÊ ; two molecules per asymmetric unit) of HFE were grown in 1:1
hanging drops containing Vibrio cholerae neuraminidase±treatedthen be expected to bind Fe-Tf with lower affinity.
HFE (14 mg/ml) and 16% (w/v) PEG 4000, 0.4 M ammonium acetate,The crystal structure of HFE and the characterization
and 0.1 M sodium citrate (pH 5.9), then improved by microseedingof its interaction with TfR reported here provide a frame-
and macroseeding. Before data collection, crystals were transferred
work for studies to elucidate the role of HFE in iron to a cryoprotectant solution (22% PEG 4000, 0.4 M ammonium ace-
homeostasis under normal circumstances and in the tate, 0.1 M sodium citrate [pH 5.9] and 7.5% glycerol). Initial data
disease state caused by iron overload. In addition, the were collected at 21508C from a single crystal to 2.9 AÊ using a MAR
Research detector at the Stanford Synchrotron Radiation Labora-structure of HFE provides the first example of the use
tory beamline 7±1. A second dataset was collected to 2.6 AÊ usingof the MHC fold for a recognition event outside of the
Fuji image plates and an off-line scanner at the Brookhaven Nationalimmune system. Despite differences in function and li-
Laboratory beamline X4A. The diffraction was anisotropic, ex-
gand specificity, the three-dimensional structures of tending beyond 2.0 AÊ along c* and to 2.6 AÊ along a* and b*. Data
classical class I molecules CD1, FcRn, and HFE are were processed and scaled with DENZO and SCALEPACK (Otwi-
remarkably similar, raising the intriguing questions of nowski and Minor, 1996) (Table 1).
why and how evolution has selected the MHC fold for
such diverse biological roles. Structure Determination and Refinement
The structure was determined by molecular replacement using
AMoRe (Navaza, 1994). A self-rotation function (15.0±4.0 AÊ ) revealedExperimental Procedures
a noncrystallographic 2-fold axis positioned at 458 in the x-y plane.
Cross-rotation and -translation functions (15.0±4.0 AÊ ) using the 2.0Expression, Purification, and Characterization
of Soluble HFE AÊ structure of HLA-A2 (PDB code 2CLR with the peptide omitted,
nonconserved side chains truncated to alanine, residues 124±156A construct encoding soluble HFE (residues 1±275 of the mature
protein) was subcloned after sequencing into the expression vector deleted) as a search model yielded a solution for the first molecule
(correlation coefficient: 26.6%; R factor of 55.0%). The second mole-PBJ5-GS that carries the glutamine synthetase gene as a selectable
marker and means of gene amplification in the presence of methio- cule was found in a partial translation function with the first molecule
fixed in which the coordinates for the first molecule were rotatednine sulfoximine (Bebbington and Hentschel, 1987). HFE and human
b2m expression vectors were cotransfected into CHO cells. Selec- according to the noncrystallographic 2-fold and used as a search
model (correlation coefficient: 29.7%; R factor of 53.2%). Rigid bodytion, amplification, and maintenance of methionine sulfoximine±
resistant cells and identification of HFE-expressing cells were done refinement (6.0±3.5 AÊ ) of both molecules resulted in an Rcryst of 50.9%
(Rfree 5 50.5%). Averaged and solvent-flattened maps calculated toas described (Chapman and Bjorkman, 1998). HFE/b2m heterodim-
ers were isolated from supernatants of cells grown in a hollow fiber 2.9 AÊ with DM (Cowtan, 1994) showed density for residues 124±156
and the a1 helix (shifted z4 AÊ relative to HLA-A2). Residues 124±156bioreactor device (Unisyn Fibertec) at yields up to 35 mg/liter using
an immunoaffinity column made with an anti-HFE monoclonal anti- were modeled using O (Jones and Kjeldgaard, 1997), and the a1
helix was positioned by rigid body refinement. Further rebuildingbody (1C3) (J. A. L., H. Shen, P. J. B., and S. Ou, unpublished data).
HFE was eluted from the 1C3 column using 50 mM diethylamine was done using averaged simulated annealing FoFave omit maps
(Hodel et al., 1992) (throughout the model in z10% increments) and(pH 11.0) into tubes containing 1M monobasic sodium phosphate,
then further purified by anion exchange chromatography using an conventional (2Fo2Fc)Fcalc and (Fo2Fc)Fcalc maps. Anisotropy and
bulk solvent corrections were applied, and the model was refinedFPLC mono Q column (Pharmacia Biotech). N-terminal sequence
analysis of purified protein yielded the sequences RLLRSHSLHYLF against the Brookhaven dataset (15±2.6 AÊ ) with tight NCS restraints
(300 kcal/mol´AÊ 2) and individual temperature (B) factors usingand IQRTPKIQVYSR corresponding to correctly processed mature
HFE and human b2m. In our numbering system, the first amino acid XPLOR (BruÈ nger, 1992a). Despite the relatively high mean B factor
each representing the indicated percent of the total binding sites.
(A) Plots of equilibrium binding response (Req) versus the log of the concentration of injected protein derived from biosensor experiments in
which the binding response closely approached or reached equilibrium. Best-fit binding curves to the experimental data points are shown as
continuous lines. KD's derived from independent experiments performed on chips coupled to different densities agreed to within a factor of
two.
(B) Sensorgrams (thick colored lines) from kinetics-based experiments overlaid with the calculated response (thin black lines) derived using
the model indicated on each panel. One representative set of injections from experiments performed in triplicate is shown for each interaction
(analyses from triplicate experiments reported in Table 4).
(C) Sensorgrams from kinetics-based experiments using TfR noncovalently coupled to a Ni-NTA chip. The HFE→TfR analysis is complicated
by a significant interaction of HFE with the Ni-NTA chip itself (blank responses and their corresponding binding responses after blank
subtraction are shown in the same color). Because the blanks represent a high proportion (more than half) of the total binding, the resulting
subtracted curves do not yield a precise value for the KD.
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Figure 5. TfR, Tf, and HFE Can Form a Ternary Complex
Individual proteins or mixtures of proteins were immunoprecipitated
with 1C3 (anti-HFE) and analyzed on a 10% reducing SDS-PAGE
gel (conditions chosen to maximize separation between TfR and
Tf). Proteins listed in parentheses were incubated together first,
followed by addition of the third protein. The b2m light chain of HFE
and the antibody light chain are present on gels composed of a
higher percentage of acrylamide (data not shown).
Comparisons to Class I-Related Proteins
and Analyses of Groove Surfaces
Alignments were performed with LSQMAN (Kleywegt, 1996) (3.0 AÊ
maximum matching distance for Ca pairs). Rms deviations for HFE
superimposed with HLA-A2 (PDB code 2CLR): 1.5 AÊ (a1; 71 Ca's),
1.2 AÊ (a2; 83 Ca's), and 0.8 AÊ (a3; 76 Ca's); FcRn (PDB code 1FRU)
superimposed with HLA-A2: 1.1 AÊ (a1; 62 Ca's), 1.6 AÊ (a2; 75 Ca's),
and 1.3 AÊ (a3; 77 Ca's); CD1 superimposed with HLA-A2: 1.2 AÊ (a1;
47 Ca's), 1.5 AÊ (a2; 71 Ca's), and 1.3 AÊ (a3; 81 Ca's).
Groove surface areas were calculated as follows. First, groove
residues were identified as those having $5.0 AÊ 2 of solvent-accessi-
ble surface area using a 1.4 AÊ probe radius but ,5.0 AÊ 2 of solvent-
accessible surface area calculated using a 5.0 AÊ probe radius in
XPLOR (BruÈnger, 1992a). Using GRASP (Nicholls et al., 1991), we
then (i) built a molecular surface of only the groove residues, (ii)
Figure 4. Gel Filtration Chromatographic Demonstration that TfR selected the contiguous groove surface between the a1 and a2
Binds to Tf and to HFE with Different Stoichiometries helices by scribing its perimeter, and (iii) calculated its surface area.
TfR and Fe-Tf (left panel) or TfR and HFE (right panel) were incubated This residue-based method of calculating groove surface areas dif-
at pH 7.4 at the indicated molar ratios, then passed over a sizing fers from the atom-based method described by Zeng et al. (1997).
column to separate TfR:Tf or TfR:HFE complexes from uncomplexed For comparison, we also used the atom-based method, which
proteins. At a 2:2 molar ratio of TfR to Tf and a 2:1 molar ratio yielded estimates for the groove surface areas in HFE (z410 AÊ 2),
of TfR to HFE, virtually all of the protein chromatographed as the class I (z690 AÊ 2), and CD1 (z1390 AÊ 2) that were similar both to the
complex. When the input ratio of TfR to Tf was greater than 2:2 values calculated with the residue-based method (see text) and to
there was excess TfR, and when it was less than 2:2 there was values previously reported (Zeng et al., 1997). However, we were
excess Tf (verified by SDS-PAGE analysis; data not shown). Like- unable to define a contiguous groove surface for FcRn using the
wise, when the input ratio of TfR to HFE was greater than 2:1 there atom-based method. The residue-based method yields a value of
was excessTfR, and when it was less than 2:1 there was excessHFE. z235 AÊ 2, approximately half of the value reported by Zeng et al.
Schematic representations of the TfR:Tf and TfR:HFE complexes (1997), presumably because the grooves were defined differently.
shown beside the chromatograms are consistent with the data,
but do not represent the only possible models accounting for the Expression, Purification, and Characterization of TfR
different stoichiometries. A soluble version of TfR, normally a type II membrane glycoprotein
(Schneider et al., 1984), was expressed in a lytic baculovirus/insect
cell expression system. The portion of the human TfR gene encoding
residues 121±760 (the C-terminal amino acid of wild-type TfR) wasof 62 AÊ 2 (Wilson B factor 5 67 AÊ 2), the model is generally well defined
in the electron density (Figure 1C). The model (Rcryst 5 23.3%; fused 39 to a gene segment encoding the hydrophobic leader pep-
tide from the baculovirus protein gp67, a 6xHis-tag, and a factor XaRfree 5 27.7%) includes 272 out of 275 residues in the recombinant
HFE heavy chain and all 99 of the residues in b2m. No ordered cleavage site in a modified version of the pAcGP67A expression
vector (Pharmingen). The N-terminal start site for soluble TfR wasdensity was observed for carbohydrate at the three potential
N-linked glycosylation sites at positions 88, 108, and 212. A large chosen based on studies of a previously characterized soluble pro-
teolytic fragment of TfR beginning at residue 121, which has beendifference electron density peak near Phe-76 in an apolar pocket
was not conclusively identified but was modeled as water in the crystallized (Borhani and Harrison, 1991) and forms a stable dimer
that binds Tf, although it lacks two interchain disulfides involvingabsence of other chemical information. Residues 1±3 are not seen
in the electron density and 14 side chains are disordered and were Cys-89 and Cys-98 (Turkewitz et al., 1988a). Recombinant virus was
generated by cotransfection of the transfer vector with linearizedmodeled as alanines (HFE residues 18, 42, 53±57, 63, 66±67, 106,
and 177; b2m residues 48 and 75). Several regions in loops include viral DNA (Baculogold; Pharmingen). TfR was purified from superna-
tants of baculovirus-infected High 5 cells using Ni-NTA chromatog-residues with real space correlation values (Jones and Kjeldgaard,
1997) below one standard deviation from the mean (residues 17±23, raphy (Ni-NTA superflow; Qiagen) followed by gel filtration chroma-
tography using a Superdex-200 FPLC column (Pharmacia). A far UV53±61, 90±91, 106±108, 174±176, 225±230).
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Table 4. Biosensor Analyses of TfR Binding to Tf and HFE
KD,eqa (nM) KD,calcb(nM) ka (sec21 M21) kd (sec21)
TfR immobilized
Fe-Tf (pH 7.5)c * 5.7 3.1 3 105 1.8 3 1023
Fe-Tf (pH 7.5)d 1.9 0.81 6 0.1 (1.6 6 0.04) 3 106 (1.3 6 0.2) 3 1023
apo-Tf (pH 6.0)e ,15 1.3 6 0.2 (7.3 6 0.7) 3 105 (9.4 6 2) 3 1024
apo-Tf 1 PPi (pH 7.5)e .8,000 N.B. N.B. N.B.
HFE (pH 7.5)f 350 130 6 10 (8.1 6 0.9) 3 105 (1.1 6 0.1) 3 1021
HFE (pH 6.0)f .10,000 N.B. N.B. N.B.
HFE immobilized
TfR (pH 7.5)g 0.91 0.33 6 0.02 (3.8 6 0.2) 3 106 (1.2 6 0.1) 3 1023
TfR (pH 6.0)g * N.B. N.B. N.B.
Fe-Tf (pH 7.5)g N.B. N.B. N.B. N.B.
apo-Tf (pH 6.0)g N.B. N.B. N.B. N.B.
* Not determined because the experiment could not be performed (see Experimental Procedures).
N.B. No significant binding at concentrations up to 1 mM.
a Determined from equilibrium binding data. Only the higher affinity of two noninteracting binding sites is reported when binding curves were
fit to a model assuming two independent classes of binding sites (see Figure 3A).
b Determined from the ratio of the kinetic constants (kd/ka) from experiments performed in triplicate when a standard deviation is given. Only
the higher affinity of two noninteracting binding sites is reported when sensorgrams were fit to a model assuming two independent classes
of binding sites (see Figure 3B).
c 6xHis-tagged TfR was noncovalently immobilized to a density of 220 RU on an Ni-NTA sensor chip (Figure 3C).
d TfR was covalently immobilized to a density of 2310 RU for the equilibrium experiments and 420 RU for the kinetic experiments.
e TfR was covalently immobilized to a density of 1460 RU for the equilibrium experiments and 420 RU for the kinetic experiments. The
equilibrium measurements at pH 6 did not fully equilibrate during the injection time, thus 15 nM is the upper limit for the KD. 10 mM PPi was
added to the buffer at pH 7.5 to prevent loading of apo-Tf with trace amounts of iron in the buffers.
f TfR was covalently immobilized to a density of 1600 RU for the equilibrium experiments and 420 RU for the kinetic experiments.
g HFE was covalently immobilized to a density of 3800 RU for the equilibrium experiments and 418 RU for the kinetic experiments.
CD spectrum of the purified protein (data not shown) verified folding solutions to the activated flowcell. For the kinetic experiments in-
volving TfR, the 6xHis-tag was removed by factor Xa (New Englandand resembled the spectrum of the proteolytic fragment of TfR
(Turkewitz et al., 1988b). Biolabs) treatment according to the manufacturer's instructions,
followed by purification on a Biospin column (Biorad). Proteins were
injected at room temperature in 50 mM PIPES (pH 6.0 or pH 7.5),Biosensor-Based Affinity Measurements
A BIAcore 1000 biosensor system (Pharmacia LKB Biotechnology) 150 mM NaCl, 0.005% BIAcore surfactant P20. All injections onto a
TfR- or HFE-coupled flowcell were followed by an identical injectionwas used to assay interactions between HFE, TfR, and human Tf
(Sigma; Fe-Tf was further purified by gel filtration chromatography). onto a mock-coupled flowcell or a flowcell coupled with an irrelevant
protein in order to subtract out significant nonspecific responses.Binding between a molecule coupled to a biosensor chip and a
second molecule injected over the chip results in changes in the To achieve a defined orientation and to avoid exposing TfR to
the low pH conditions required for primary amine coupling (whichSPR signal that are read out in real time as resonance units (RU)
(Malmqvist and Granzow,1994). We derived equilibrium dissociation produce a conformational change resulting in self-association at
pH ,6 [Turkewitz et al., 1988b]; J. A. L., P. J. B., and P. Poon,constants (KD's) whenever possible using two methods. In the first
(KD,eq column in Table 4), binding reactions were allowed to closely unpublished data), we injected soluble HFE over 6xHis-tagged TfR
noncovalently coupled to a biosensor chip derivatized with Ni-NTA.approach or to reach equilibrium by using long injections (50 min)
with slow flow rates (5 ml/min) over biosensor chips coupled to Only kinetic experiments were performed using this chip, since the
amount of His-tagged TfR released from the Ni-NTA chip becamehigh densities (.1000 RU). KD,eq values were derived by nonlinear
regression analysis of plots of Req (the equilibrium binding response) significant during the long injections required for the equilibrium-
based measurements. The Ni-NTA chip could not be used for bind-versus the log of the concentration of the injected protein (Figure
3A). The fit of data to binding models assuming one or more classes ing studies at pH 6.0, as the 6xHis interaction with nickel is not
stable at this pH.of interacting or noninteracting binding sites was then examined,
and the appropriate model was chosen as described (Vaughn and
Bjorkman, 1997). In the second method (KD,calc in Table 4; KD,calc 5 Gel Filtration Analyses of TfR-Tf and TfR-HFE Stoichiometries
Protein concentrations were determined spectrophotometrically atkd/ka; ka and kd are the association and dissociation rate constants,
respectively), kinetic constants were derived from binding experi- 280 nm using the following extinction coefficients: HFE, 96570
M21cm21; TfR monomer, 93790 M21cm21; Tf, 83360 M21cm21. Extinc-ments conducted for shorter times (2±4 min) using faster flow rates
(50 ml/min) over chips coupled at lower densities (z400 RU). These tion coefficients were first calculated from the protein sequences,
then A280 measurements for a fixed amount of each protein wereconditions were chosen to minimize mass transport effects upon
the kinetics of binding reactions (Karlsson and FaÈ lt, 1997), which compared in 6 M GuHCl and aqueous solutions and the coefficient
was adjusted if necessary. For the TfR:Tf experiments, molar ratiosare not a concern for the equilibrium measurements. Kinetic con-
stants werederived from sensorgram data using simultaneous fitting from 3:2 to 1:2 of TfR and Fe-Tf were incubated for 20 min at room
temperature in 20 mM Tris (pH 7.4), 150 mM NaCl, 0.02% NaN3,to the association and dissociation phases of the interaction and
global fitting to all curves in the working set (Figures 3B and 3C) as keeping the amount of TfR fixed at 200 pmol in a total volume of
25 ml. For the TfR:HFE experiments, molar ratios from 3:1 to 1:1 ofimplemented in BIAevaluation version 3.0.
TfR (20 mg/ml in 5 mM maleate [pH 6.0]) or HFE (55 mg/ml in 20 TfR and HFE were incubated as described above, keeping the
amount of HFE fixed at 360 pmol in a total volume of 25 ml. SamplesmM sodium acetate [pH 5.0]) was immobilized using standard amine
coupling chemistry on a CM5 chip (Pharmacia LKB Biotechnology). (25 ml) were injected onto a Superose 6B FPLC column (Pharmacia),
eluted with the same buffer at 0.5 ml/min, and the fractions analyzedHigher coupling densities for the equilibrium-based experiments
were achieved by increasing the time of exposure of the protein by SDS-PAGE (data not shown).
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Coimmunoprecipitation of HFE, TfR, Cowtan, K. (1994). Joint CCP4 and ESF-EACBM Newsletter on Pro-
tein Crystallography 31, 34±38.and Tf in a Ternary Complex
TfR (138 pmol), Fe-Tf (138 pmol), and HFE (69 pmol) were incubated Cuthbert, J.A. (1997). Iron, HFE, and hemochromatosis update. J.
for 15 min at room temperature in 20 mM Tris (pH 7.4), 150 mM Invest. Med. 45, 518±529.
NaCl, 0.025% NaN3 (incubation buffer). All three proteins were incu- Enns, C.A., and Sussman, H.H. (1981). Physical characterization of
bated for 15 min or two of the proteins were preincubated for 15 the transferrin receptor in human placentae. J. Biol. Chem. 256,
min, followed by addition of the third protein and a second 15 min 9820±9823.
incubation. The reaction mixture was then diluted from 130 ml to 1
Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A.,ml using the same buffer, and 5 ml of ascites containing the 1C3
Basava, A., Dormishian, F., Domingo, R., Ellis, M.C., Fullan, A., etanti-HFE monoclonal antibody were added. After incubation for 60
al. (1996). A novel MHC class I-like gene is mutated in patients withmin at room temperature, 30 ml of protein G beads (Pharmacia; 2
hereditary hemochromatosis. Nature Genet. 13, 399±408.mg of protein G/ml of beads) were added, and incubated with mixing
Feder, J.N., Tsuchihashi, Z., Irrinki, A., Lee, V.K., Mapa, F.A., Mori-for 60 min. After pelleting, the beads were washed once with incuba-
kang, E., Prass, C.E., Starnes, S.M., Wolff, R.K., Parkkila, S., et al.tion buffer, twice with phosphate buffered saline, 0.05% Tween 20
(1997). The hemochromatosis founder mutation in HLA-H disrupts(Sigma), and once again with incubation buffer, then boiled in 20 ml
b2-microglobulin interaction and cell surface expression. J. Biol.of SDS-PAGE loading buffer containing 10% (v/v) 2-mercaptoetha-
Chem. 272, 14025±14028.nol and loaded onto a 10% SDS-PAGE gel (Figure 5). Bands corre-
Feder, J.N., Penny, D.M., Irrinke, A., Lee, V.K., LebroÂ n, J.A., Watson,sponding to the individual proteins were identified by comparison
N., Tsuchihashi, Z., Sigal, E., Bjorkman, P.J., and Schatzman, R.C.with the migration of samples of purified proteins (data not shown).
(1998). The hemochromatosis gene product complexes with the
transferrin receptor and lowers its affinity for ligand binding. Proc.Acknowledgments
Natl. Acad. Sci. USA 95, 1472±1477.
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